Funded Health Care Startups
In the 50 most recent funded Health Care rounds shown (through 2025-11-25), the largest disclosed amount is Function Health’s $298M round on 2025-11-18, wh…
In the 50 most recent funded Health Care rounds shown (through 2025-11-25), the largest disclosed amount is Function Health’s $298M round on 2025-11-18, which dwarfs the next-largest disclosed entries clustered in the $150M–$200M band (e.g., VeraDermics $150M on 2025-10-13 and Synchron $200M on 2025-11-08). Funding sizes also show a wide spread: the smallest disclosed amount is Good Life Sorted’s $30K on 2025-10-02, far below most other disclosed rounds (many are $1M–$30M). Geographically, San Francisco appears repeatedly (e.g., Intellihealth 2025-11-25 $5M; House Rx 2025-11-16 $55M; Mecha Health 2025-11-06 $4M; Daymark Health 2025-09-28 $20M; AmplifyMD 2025-09-26 $20M), with other strong secondary hubs in New York (Synchron 2025-11-08 $200M; Medmo 2025-10-19 $15M; Duos 2025-10-10 $130M). Date-wise, the list concentrates in late 2025, with the most recent round on 2025-11-25 (Intellihealth) and the oldest shown on 2025-09-21 (Arab Therapy, Mindset Medical). Stage classification is mixed: “Series Unknown” appears 11 times and “undisclosed” appears 7 times.
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the largest disclosed round in these recent Health Care entries, and how far above the rest is it?
Function Health’s $298M (2025-11-18) is the standout: it’s the only disclosed round shown near the high-$200M level, while the next-largest disclosed amounts are notably lower (e.g., Synchron $200M on 2025-11-08; VeraDermics $150M on 2025-10-13).
Which cities look most represented, and is the pattern driven by a single hub?
San Francisco is the clearest city cluster, with multiple entries across dates and sizes, including Intellihealth ($5M, 2025-11-25), House Rx ($55M, 2025-11-16), Mecha Health ($4M, 2025-11-06), Daymark Health ($20M, 2025-09-28), and AmplifyMD ($20M, 2025-09-26). New York also appears multiple times (e.g., Synchron $200M, 2025-11-08; Duos $130M, 2025-10-10; Medmo $15M, 2025-10-19), but San Francisco is the more repeated concentration in this slice.
How much of the list is in the most recent window, and where do the latest rounds concentrate?
The newest date is 2025-11-25 (Intellihealth), and several follow within days: Ember Copilot ($4M, 2025-11-23) and Reimagine Care ($2M, 2025-11-21) precede larger later-November rounds like Function Health ($298M, 2025-11-18) and Synchron ($200M, 2025-11-08). The oldest shown date is 2025-09-21 (Arab Therapy and Mindset Medical), so the whole set is tightly bounded to late Q3 through November 2025.
What stage labels dominate, and how often are rounds not clearly classified by stage?
Stage mix is split between identifiable labels and missing detail: “Series Unknown” appears 11 times and “undisclosed” amounts appear 7 times in the 50 rows. Among clearly labeled stages, Series A and Series B show frequent recurrence (e.g., NextSense Series A $16M on 2025-11-12; Medmo Series A $15M on 2025-10-19; House Rx Series B $55M on 2025-11-16), but the presence of “Series Unknown” and “undisclosed” is large enough to skew any stage-based read.
Are there funding-size outliers that would change how an analyst groups deals?
Yes. The smallest disclosed round is Good Life Sorted at $30K on 2025-10-02, while the largest disclosed round is Function Health at $298M on 2025-11-18; in between, many disclosed rounds fall into a mid-range such as $1M–$30M (e.g., DifferentKind $300K on 2025-11-14; Medmo $15M on 2025-10-19; Foundation Health $20M on 2025-10-12). Analysts looking for comparable deal sizes should treat both ends as separate buckets.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.